Cargando…

Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel Chemotherapy

PURPOSE: Dose-limiting toxicities of docetaxel are widely considered to be neutropenia, anemia, skin toxicity, and nausea. One of the factors that limit the use of docetaxel is its unpredictability of inter-individual variation in toxicity. MATERIALS AND METHODS: In order to identify the genetic fac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Jung Ran, Kim, Jeong-Oh, Kang, Dae Ryong, Shin, Jung-Young, Zhang, Xiang Hua, Oh, Ji Eun, Park, Ji-Young, Kim, Kyoung-Ah, Kang, Jin-Hyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506105/ https://www.ncbi.nlm.nih.gov/pubmed/25648089 http://dx.doi.org/10.4143/crt.2014.012

Ejemplares similares

A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy
por: Won, Young-Woong, et al.
Publicado: (2023)

Nail Changes During Docetaxel Containing Combination Chemotherapy
por: Woo, In Sook, et al.
Publicado: (2004)

Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
por: Lee, Ji Hyun, et al.
Publicado: (2013)

Prognostic role of beclin-1 in locally advanced non-small cell lung cancer in patients receiving docetaxel-platinum induction chemotherapy
por: Lee, Hee Yeon, et al.
Publicado: (2019)

Drug–Drug interactions of docetaxel in patients with breast cancer based on insurance claims data
por: Shin, Kwang-Hee, et al.
Publicado: (2023)

ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy
por: Kim, Hee-Jun, et al.
Publicado: (2015)

Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema
por: Lim, Hyun-Kyung, et al.
Publicado: (2016)

Effect of the Phragmitis rhizoma Aqueous Extract on the Pharmacokinetics of Docetaxel in Rats
por: Shin, Sarah, et al.
Publicado: (2019)

Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer
por: Hong, Woo Sung, et al.
Publicado: (2013)

Tryptophanyl-tRNA Synthetase Sensitizes Hormone Receptor-Positive Breast Cancer to Docetaxel-Based Chemotherapy
por: Lee, Kyung-Min, et al.
Publicado: (2020)

A CDK4/6 inhibitor enhances cytotoxicity of paclitaxel in lung adenocarcinoma cells harboring mutant KRAS as well as wild-type KRAS
por: Zhang, Xiang-Hua, et al.
Publicado: (2013)

Current trends in intravenous sedative drugs for dental procedures
por: Yoon, Ji-Young, et al.
Publicado: (2016)

Complete Remission of Unresectable Colon Cancer after Preoperative Chemotherapy Selected by Adenosine Triphosphate-Based Chemotherapy Response Assay
por: Huh, Jung Wook, et al.
Publicado: (2008)

Radon Exposure-induced Genetic Variations in Lung Cancers among Never Smokers
por: Choi, Jung Ran, et al.
Publicado: (2018)

Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy
por: Kim, Hong Jun, et al.
Publicado: (2020)

Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1
por: Jung, Joo Young, et al.
Publicado: (2016)

Coreolanceolins A–E, New Flavanones from the Flowers of Coreopsis lanceolate, and Their Antioxidant and Anti-Inflammatory Effects
por: Kim, Hyoung-Geun, et al.
Publicado: (2020)

Docetaxel Chemotherapy of Korean Patients with Hormone-refractory Prostate Cancer : Comparative Analysis between 1st-line and 2nd-line Docetaxel
por: Joung, Jae Young, et al.
Publicado: (2008)

Cloaking nanoparticles with protein corona shield for targeted drug delivery
por: Oh, Jun Yong, et al.
Publicado: (2018)

Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugs
por: Choi, Jinhyang, et al.
Publicado: (2015)

Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information
por: Jang, Ha Young, et al.
Publicado: (2022)

Adherence to Varenicline and Abstinence Rates for Quitting Smoking in a Private Health Promotion Center-Based Smoking Cessation Clinic
por: Lee, Jin-Young, et al.
Publicado: (2012)

Anti-Inflammatory Effect of Flavonoids from Brugmansia arborea L. Flowers
por: Kim, Hyoung-Geun, et al.
Publicado: (2020)

Improved Fluoroquinolone-Resistant and Extensively Drug-Resistant Tuberculosis Treatment Outcomes
por: Lee, Eun Hye, et al.
Publicado: (2019)

Histologic Grade and Decrease in Tumor Dimensions Affect Axillary Lymph Node Status after Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Kim, Tae Hee, et al.
Publicado: (2015)

A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
por: Ji, Sang Hoon, et al.
Publicado: (2009)

Comparison of Doxorubicin Plus Docetaxel Neoadjuvant Chemotherapy with Doxorubicin Plus Vinorelbine in Primary Breast Cancer
por: Gwak, Geumhee, et al.
Publicado: (2011)

A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine
por: Lee, Keun-Wook, et al.
Publicado: (2017)

A low risk of nosocomial transmission of subclinical tuberculosis to neonates in a postpartum care center under COVID-19 control measures
por: Kim, In Kyoung, et al.
Publicado: (2022)

A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer
por: Yoo, Changhoon, et al.
Publicado: (2015)

A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
por: Jeon, Ye Won, et al.
Publicado: (2017)

Functionalized Lipid Nanocarriers for Simultaneous Delivery of Docetaxel and Tariquidar to Chemoresistant Cancer Cells
por: Kim, Chang Hyun, et al.
Publicado: (2023)

The Reversal of Drug-Resistance in Tumors Using a Drug-Carrying Nanoparticular System
por: Oh, Kyung Taek, et al.
Publicado: (2009)

Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
por: Lee, S-H, et al.
Publicado: (2004)

Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma
por: Kim, Min-Young, et al.
Publicado: (2020)

Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study
por: Kim, Se Hyun, et al.
Publicado: (2016)

Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
por: Oh, S C, et al.
Publicado: (2005)

Comparison of therapeutic responses to an anticancer drug in three stocks of ICR mice derived from three different sources
por: Sung, Ji Eun, et al.
Publicado: (2017)

Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug
por: Lee, Hee Sook, et al.
Publicado: (2012)

Comparison of responsiveness to cancer development and anti-cancer drug in three different C57BL/6N stocks
por: Kang, Mi Ju, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_265g23ab0adepou2r8gjfi19f7